Problem
Many of the 11,000 in the US and 800,000 globally who die from stomach cancer each year are diagnosed too late for doctors to save their lives. They don’t receive traditional upper endoscopy (EGD) because facilities and personnel are overbooked. By enabling telemedicine stomach cancer screening, even for people who don’t live near a hospital, PillBot™ will save lives at the same time that it eases burdens on facilities and allows GI doctors to treat more patients. PillBot™ will be a giant step in telemedicine, permitting equal access to lifesaving technology.